Literature DB >> 19003946

Inhibitory effects of antrodins A-E from Antrodia cinnamomea and their metabolites on hepatitis C virus protease.

Do Thi Phuong1, Chao-Mei Ma, Masao Hattori, Jong Sik Jin.   

Abstract

Antrodia cinnamomea is a highly valued folk medicine used for liver cancer, a disease often caused by the long term infection of hepatitis C virus (HCV). In the present study, the maleic and succinic acid constituents (antrodins A-E) of this medicinal fungus, the in vivo metabolites of antrodin C and the analogue of one of the metabolites were tested for their inhibitory activity on HCV protease. Most of the compounds showed potent inhibitory activity, with antrodin A being the most potent (IC(50) = 0.9 microg/mL). Antrodin A was isolated as one of the constituents of A. cinnamomea and was also detected as an in vivo metabolite of the major constituent antrodin C. The mode of inhibition for antrodin A on HCV protease was revealed by a Lineweaver-Burk plot as competitive inhibition. These results strongly support the use of this folk medicine for liver cancer and HCV infection which is a global problem. (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19003946     DOI: 10.1002/ptr.2657

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  15 in total

1.  Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.

Authors:  Deng-wei Wu; Fei Mao; Yan Ye; Jian Li; Chuan-lian Xu; Xiao-min Luo; Jing Chen; Xu Shen
Journal:  Acta Pharmacol Sin       Date:  2015-08-17       Impact factor: 6.150

2.  Oxidative Stress Induction Is a Rational Strategy to Enhance the Productivity of Antrodia cinnamomea Fermentations for the Antioxidant Secondary Metabolite Antrodin C.

Authors:  Peng-Fei Hu; Jing Huang; Lei Chen; Zhongyang Ding; Liming Liu; István Molnár; Bo-Bo Zhang
Journal:  J Agric Food Chem       Date:  2020-03-19       Impact factor: 5.279

Review 3.  Advancements in tetronic acid chemistry. Part 2: Use as a simple precursor to privileged heterocyclic motifs.

Authors:  Moaz M Abdou; Rasha A El-Saeed; Khaled M Elattar; Zeynel Seferoğlu; John Boukouvalas
Journal:  Mol Divers       Date:  2016-06-27       Impact factor: 2.943

4.  Antcin H Protects Against Acute Liver Injury Through Disruption of the Interaction of c-Jun-N-Terminal Kinase with Mitochondria.

Authors:  Yazhen Huo; Sanda Win; Tin Aung Than; Shutao Yin; Min Ye; Hongbo Hu; Neil Kaplowitz
Journal:  Antioxid Redox Signal       Date:  2016-10-11       Impact factor: 8.401

5.  Development of a cell-based hepatitis C virus infection fluorescent resonance energy transfer assay for high-throughput antiviral compound screening.

Authors:  Xuemei Yu; Bruno Sainz; Susan L Uprichard
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

6.  Integrated strategy of pH-shift and glucose feeding for enhanced production of bioactive Antrodin C in submerged fermentation of Antrodia camphorata.

Authors:  Huan Zhang; Yong-Dan Hu; Rui-Qiu Lu; Yong-Jun Xia; Bo-Bo Zhang; Gan-Rong Xu
Journal:  J Ind Microbiol Biotechnol       Date:  2014-05-29       Impact factor: 3.346

Review 7.  HCV drug discovery aimed at viral eradication.

Authors:  R F Schinazi; L Bassit; C Gavegnano
Journal:  J Viral Hepat       Date:  2009-12-18       Impact factor: 3.728

8.  Review of Pharmacological Effects of Antrodia camphorata and Its Bioactive Compounds.

Authors:  Madamanchi Geethangili; Yew-Min Tzeng
Journal:  Evid Based Complement Alternat Med       Date:  2011-01-03       Impact factor: 2.629

9.  Current evidence for the hepatoprotective activities of the medicinal mushroom Antrodia cinnamomea.

Authors:  Patrick Ying-Kit Yue; Yi-Yi Wong; Kay Yuen-Ki Wong; Yeuk-Ki Tsoi; Kelvin Sze-Yin Leung
Journal:  Chin Med       Date:  2013-11-01       Impact factor: 5.455

10.  Antrodia cinnamomea alleviates cisplatin-induced hepatotoxicity and enhances chemo-sensitivity of line-1 lung carcinoma xenografted in BALB/cByJ mice.

Authors:  Tse-Hung Huang; Yi-Han Chiu; Yi-Lin Chan; Hang Wang; Tsung-Lin Li; Chien-Yin Liu; Cheng-Ta Yang; Tzung-Yan Lee; Jyh-Sheng You; Kuang-Hung Hsu; Chang-Jer Wu
Journal:  Oncotarget       Date:  2015-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.